Roth Capital Estimates Bio-Path’s Q1 Earnings (NASDAQ:BPTH)
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Equities researchers at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for shares of Bio-Path in a report released on Sunday, March 30th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings of ($0.38) per share for the quarter, up […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Equities researchers at Roth Capital boosted their Q1 2025 earnings per share (EPS) estimates for shares of Bio-Path in a report released on Sunday, March 30th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings of ($0.38) per share for the quarter, up […]
